Switch Therapeutics Appoints Douglas Fambrough, Ph.D., to Board of Directors
Park Square is pleased to announce the placement of Doug Fambrough to the Board of Directors at Switch Therapeutics.
{
Switch Therapeutics, a biotechnology company pioneering a new way to use RNA science to treat disease, utilizing its proprietary CASi...…
